SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950134-05-006641
Filing Date
2005-03-31
Accepted
2005-03-31 21:46:42
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d23980e10vk.txt 10-K 293629
2 SUBSIDIARIES d23980exv21.txt EX-21 393
3 CONSENT OF GRANT THORNTON LLP d23980exv23w1.txt EX-23.1 1085
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 d23980exv31w01.txt EX-31.01 4373
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 d23980exv31w02.txt EX-31.02 4423
6 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 d23980exv32w01.txt EX-32.01 2076
  Complete submission text file 0000950134-05-006641.txt   307670
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 05722732
SIC: 2834 Pharmaceutical Preparations